Unlocking the Power of Collaboration to Fuel Industry Transformation Workshop

The groundwork for seamless cell and gene therapy (CGT) care delivery needs to be laid now. There are many stakeholders involved in the complexities of the CGT treatment journey that require a radically new approach from that of traditional mass-produced therapies. A complex balancing act of multi-stakeholder processes hinge on treatment advances, product availability, and the network’s ability to meet demand. And that’s before thinking about scaling CGT delivery to more than a few thousand patients. This workshop will bring together leading experts in managing interconnected supply and logistics networks, delivering superior patient experiences, manufacturing cell and gene therapies, and building world-class digital infrastructures.

Chair:
Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader, EY

Speakers:
Sybil Danby, Senior Vice President, Business Development and Strategy, Center for Breakthrough Medicines
Tamie Joeckel, Global Business Lead, Cell and Gene Therapy COE, ICON
Orlando Serani, Program Lead Advanced Cellular Therapies Supply Chain, Johnson & Johnson
Julia Tarasenko, Vice President, Commercial Operations, Europe and the Americas, Marken, a UPS Healthcare company